Schreiner MediPharm, a leading developer and manufacturer of functional labels for the healthcare industry, has developed a multifunctional specialty label for SHL Medical’s Quanta™ Pen. The label combines user convenience, safety, and digital connectivity – all key benefits as the global market for weight management drugs experiences dynamic growth, and continues to seek powerful self-injection systems.
The newly developed functional label from Schreiner MediPharm is an ideal complement to the Quanta™ Pen from SHL Medical, an injector platform specifically designed for long-term cardiometabolic therapies. The multi-fixed-dose pen platform combines fixed-dose reliability with a no-priming design to deliver consistent performance across repeated injections while supporting cost-efficient treatment delivery. Schreiner MediPharm’s precision-fit label adds functional and digital features to the pen.
Enhancing Self-Injection with SHL Medical’s Quanta™ Pen
As demand for weight management therapies continues to grow, pharmaceutical companies are increasingly focused on solutions that support scalability, usability, and differentiation. The combination of SHL Medical’s Quanta™ Pen and Schreiner MediPharm’s functional label brings these elements together by combining a multi-fixed-dose pen platform with value-adding label technologies. The label from Schreiner MediPharm carries SHL Medical’s branding, and integrates functional value-adding features such as an anti-slip varnish for better grip and safe handling, as well as a holographic effect as an overt authentication feature. Together, the pen and label can support implementation efficiency while strengthening the overall product presentation.
As a special feature, the label includes an NFC chip enabling a variety of possibilities for digital applications. Product information, user instructions, or service offerings can be easily accessed by end users via smartphone. At the same time, the functional label offers additional options for customized differentiation. Other security, design, and functional elements can be flexibly integrated to enable targeted adaptation to specific product brands and applications.
The joint project by Schreiner MediPharm and SHL Medical combines the strengths of two leading specialists. While SHL Medical provides a powerful platform for modern self-injection solutions with the Quanta™ Pen, Schreiner MediPharm complements it with smart label technologies. The result is a flexible comprehensive solution enhancing functionality, connectivity, and brand appearance while opening up new differentiation potential for pharmaceutical companies.
